Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients

Journal of Cystic Fibrosis

Volumn 11, Issue 4, 2012, Pages 349-352

  Rao, Priyanka ^a,b   McCaughan, John ^c   McCalmont, Mark ^c   Goldsmith, Colin E ^a   Hall, Valerie ^a   Millar, B Cherie ^a   McCann, Mary Ann ^a   Downey, Damian G ^a   Rendall, Jacqueline C ^a   Elborn, J Stuart ^a,d   Moore, John E ^a,e  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b Bloomfield Collegiate   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Antibiotic resistance; Cystic fibrosis; Multiresistant; Panresistant; Pseudomonas aeruginosa; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEMOCILLIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CYSTIC FIBROSIS; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84863394650     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.01.002     Document Type: Letter

References (11)

1. Lyczak J.B., Cannon C.L., Pier G.B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15:194-222.
2. Rajan S., Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 2002, 17:47-56.
3. Pitt T.L., Sparrow M., Warner M., Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 2003, 58:794-796.
4. Anon UK CF Trust Registry Available at, Last accessed. http://www.cftrust.org.uk/.
5. Davies G., McShane D., Davies J.C., Bush A. Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation. Pediatr Pulmonol 2003, 35:253-256.
6. Bosso J.A., Mauldin P.D., Steed L.L. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Ann Pharmacother 2006, 40:1946-1949.
7. Manno G., Cruciani M., Romano L., Scapolan S., Mentasti M., Lorini R., et al. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Int J Antimicrob Agents 2005, 25:193-197.
8. Phaff S.J., Tiddens H.A., Verbrugh H.A., Ott A. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J Antimicrob Chemother 2006, 57:741-746.
9. Tazumi A., Maeda Y., Goldsmith C.E., et al. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). J Antimicrob Chemother 2009, 64:501-506.
10. Maeda Y., Murayama M., Goldsmith C.E., et al. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis. J Antimicrob Chemother 2011, 66:476-486.
11. Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006, 55:1619-1629.